Drug Profile
Ketoconazole - HRA Pharma
Alternative Names: Ketoconazole HRALatest Information Update: 06 May 2022
Price :
$50
*
At a glance
- Originator HRA Pharma
- Class Antifungals; Azoles; Piperazines; Small molecules
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cushing syndrome
Most Recent Events
- 02 May 2022 HRA Pharma has been acquired by Perrigo
- 05 Feb 2019 Chemical structure information added
- 24 Mar 2017 No recent reports of development identified - Registered for Cushing's syndrome (In adolescents, In adults) in Norway, Liechtenstein, Iceland (PO)